v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net loss $ (58,579) $ (31,610)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,452 1,319
Equity-based compensation 4,324 4,244
Change in fair value of warrants (6,041) 13,176
Debt extinguishment loss 13,734
Issuance of common warrants 5,766
Change in fair value of derivative liability 24,523
Realized and unrealized gain on short term investments (338) (50)
Equity method investment loss 39 40
Asset retirement obligation accretion 26 16
Amortization of debt discount 1,739 1,442
Changes in operating assets and liabilities:    
Accounts receivable 1,656 836
Other current assets (749) (434)
Other assets 16 (107)
Accounts payable 273 878
Deferred revenue 22 (10)
Accrued expenses and other liabilities (254) 3,022
Operating lease right-of-use assets and liabilities 212 253
Net cash used in operating activities (12,179) (6,985)
Investing activities    
Purchases of network assets, property, and equipment (30) (32)
Purchase of internal use software (101) (163)
Purchase of marketable securities (31,463) (5,918)
Sale and maturity of marketable securities 34,600 4,000
Net cash provided by (used in) investing activities 3,006 (2,113)
Financing activities    
Proceeds from 2028 senior convertible notes 190,000
Repayment of 2026 senior secured notes (70,000)
Payments towards debt issuance cost (550)
Payments towards debt (27) (28)
Proceeds from exercise of common warrants 517
Proceeds from exercise of common stock options 232 544
Net cash provided by financing activities 120,172 516
Effect of exchange rates on cash and cash equivalents 93 21
Net increase (decrease) in cash and cash equivalents 111,092 (8,561)
Cash and cash equivalents at beginning of period 39,330 81,878
Cash and cash equivalents at end of period 150,422 73,317
Non-cash investing and financing information    
Capital expenditure included in Accrued expenses and other current liabilities $ 22 $ 278